SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001824293-23-000098
Filing Date
2023-04-24
Accepted
2023-04-24 18:27:11
Documents
2
Period of Report
2023-04-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_168237521860433.html 3  
1 FORM 3 wf-form3_168237521860433.xml 3 1740
2 EX-24.1 - POWER OF ATTORNEY SZEKERES gri-form3ex241section16poa.htm EX-24 3568
  Complete submission text file 0001824293-23-000098.txt   6835
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT, SUITE 210 SAN DIEGO CA 92121
Business Address
Szekeres David Leslie (Reporting) CIK: 0001602459 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40034 | Film No.: 23841231

Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Issuer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations